hg_232660.1

Basic information about the TSS

---

TSS ID: hg_232660.1 Species: human Chr: chr11		Start: 118759488 End: 118759489 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000529162.1 AK093657 Distance: 120 GeneID: 1656 HGNC/MGI_ID: HGNC:2747 UniProt_ID:

Gene_name: DEAD-box helicase 6 Gene_symbol: DDX6 Gene_synonyms: RCK Rck/p54 Gene_source: HGNC:2747

TATA-Box annotation

---

Distance to TSS:	882
Nearest PromoterID:	NM_001286570
Entrez ID:	120425
Nearest Unigene:	Hs.16291
Nearest Refseq:	NM_153206
Nearest Ensembl:	ENSG00000160593
Gene Name:	DEAD-box helicase 6
Gene Alias:	AMICA|AMICA1|CREA7-1|CREA7-4|Gm638
Gene Description:	junction adhesion molecule like
Gene Type:	protein-coding
CpG%:	0.025
GC%:	0.437811
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@DDX6 p3@DDX6 p4@DDX6
Sample		p1@DDX6	p3@DDX6	p4@DDX6
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	33.12	16.95	1.56
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	35.41	14.57	2.23
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	36.07	18.33	1.74
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	34.93	11.85	3.12
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	29.70	15.75	2.92
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	32.75	12.99	1.94
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	43.58	23.75	2.61
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	32.70	13.56	5.09
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	33.13	15.39	2.35
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	41.15	25.50	4.06
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	39.21	19.00	2.02
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	40.66	19.92	2.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	41.91	12.90	2.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	32.78	15.79	4.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	39.08	16.03	3.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	28.17	11.32	2.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	25.77	11.36	1.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	33.32	12.23	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	28.79	9.60	3.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	35.05	12.04	3.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	32.08	14.30	3.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	33.32	19.51	3.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	32.70	14.35	3.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	22.08	12.13	3.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	40.25	14.71	3.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	41.15	11.71	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	47.25	13.74	3.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	45.74	24.99	3.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	37.31	18.09	3.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	44.70	21.17	4.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	32.66	17.58	3.14
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	48.26	20.91	3.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	40.10	21.10	2.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	51.63	28.04	8.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	40.20	21.13	3.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	31.81	18.01	3.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	30.04	15.74	3.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	25.19	14.10	3.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	39.16	25.12	4.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	29.53	19.93	6.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	23.29	14.59	3.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	30.60	22.25	5.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	18.77	16.66	2.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	28.50	16.78	4.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	34.13	25.10	6.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	27.45	22.57	4.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	25.19	15.59	2.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	35.77	16.39	5.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	22.26	15.56	3.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	33.77	17.59	4.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	38.33	20.70	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	37.14	15.79	1.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	195.89	97.95	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	17.74	12.77	2.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	21.54	8.95	1.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	101.51	73.83	5.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	55.57	22.96	2.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	18.15	11.02	2.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	12.85	5.46	2.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	56.58	33.63	3.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	19.04	7.05	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	17.38	9.53	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	122.61	58.91	6.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	60.48	19.03	1.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	20.15	6.50	2.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	20.59	4.97	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	80.82	80.82	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	181.64	39.49	15.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	17.06	8.78	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	19.83	8.93	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	21.11	9.85	1.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	55.31	12.59	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	18.25	8.97	2.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	25.07	5.50	1.22
Adipocyte - breast, donor1	11376-118A8	35.32	16.95	1.58
Adipocyte - breast, donor2	11327-117E4	30.64	13.48	4.33
Adipocyte - omental, donor1	11473-119C6	46.31	24.55	3.82
Adipocyte - omental, donor2	11474-119C7	29.90	10.46	2.24
Adipocyte - omental, donor3	11475-119C8	28.13	9.71	1.34
Adipocyte - perirenal, donor1	11476-119C9	27.43	7.02	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	13.19	3.30	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	35.23	9.48	1.35
Adipocyte - subcutaneous, donor3	11408-118E4	30.41	9.73	2.09
Adipocyte differentiation, day04, donor1	13019-139D4	62.78	25.03	4.30
Adipocyte differentiation, day04, donor2	13022-139D7	37.32	7.21	1.54
Adipocyte differentiation, day04, donor3	13025-139E1	31.22	10.87	1.39
Adipocyte differentiation, day04, donor4	13028-139E4	34.68	13.52	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	76.01	22.60	9.49
Adipocyte differentiation, day08, donor2	13023-139D8	30.98	10.33	1.94
Adipocyte differentiation, day08, donor3	13026-139E2	47.99	20.26	4.27
Adipocyte differentiation, day08, donor4	13029-139E5	36.72	9.46	2.23
Adipocyte differentiation, day12, donor1	13021-139D6	22.87	13.72	2.50
Adipocyte differentiation, day12, donor2	13024-139D9	34.16	11.30	1.51
Adipocyte differentiation, day12, donor3	13027-139E3	31.74	15.71	3.93
Adipocyte differentiation, day12, donor4	13030-139E6	25.27	13.70	3.04
Alveolar Epithelial Cells, donor1	11510-119G7	24.31	3.54	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	3.59	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	2.40	1.20	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	21.77	5.76	1.08
Amniotic Epithelial Cells, donor2	11613-122A2	15.06	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	17.46	5.55	1.03
Anulus Pulposus Cell, donor1	11248-116E6	54.92	17.16	3.55
Anulus Pulposus Cell, donor2	11463-119B5	36.25	15.67	4.16
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	24.71	15.73	2.70
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	28.65	14.33	3.04
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	32.10	4.28	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	24.81	16.74	2.99
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	27.82	5.06	3.79
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	20.46	11.22	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	24.04	10.07	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	26.21	18.45	3.40
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	20.79	10.69	2.97
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	23.73	13.18	4.14
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	18.87	17.42	2.18
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	8.78	7.52	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	33.28	14.33	1.81
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	30.03	15.01	2.73
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	30.01	13.42	1.81
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	23.04	18.75	2.14
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	23.99	13.79	3.40
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	25.66	12.03	1.87
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	17.56	13.66	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	27.04	13.43	3.15
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	16.81	8.41	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	53.10	10.62	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	29.85	12.86	3.60
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	28.64	12.62	1.94
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	33.77	15.94	4.17
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	19.38	10.90	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	24.51	10.26	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	26.72	13.68	2.78
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	20.91	10.84	1.03
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	21.58	12.67	1.41
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	21.22	13.83	1.61
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	15.70	12.84	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	22.23	12.87	2.34
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	27.70	10.84	2.11
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	19.01	14.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	24.41	13.73	4.07
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	29.80	11.21	3.06
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	12.71	10.17	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	22.44	12.08	3.88
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	27.52	11.85	2.96
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	15.66	8.41	0.87
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	24.56	10.39	2.83
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	24.24	10.85	1.36
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	20.85	6.95	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	33.80	12.68	6.34
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	25.73	10.29	3.22
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	16.24	7.22	1.80
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	32.07	8.02	3.64
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	30.34	15.17	2.76
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	25.50	10.20	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	32.03	12.20	3.05
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	26.63	16.93	3.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	20.50	14.99	1.84
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	24.86	16.25	6.21
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	24.17	12.86	3.99
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	13.73	3.05	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	25.48	9.42	3.88
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	22.51	14.56	3.44
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	19.99	9.81	2.54
Astrocyte - cerebellum, donor1	11500-119F6	39.55	6.63	1.97
Astrocyte - cerebellum, donor2	11580-120F5	11.30	1.71	0.00
Astrocyte - cerebellum, donor3	11661-122F5	7.97	3.36	0.63
Astrocyte - cerebral cortex, donor1	11235-116D2	80.52	28.58	3.83
Astrocyte - cerebral cortex, donor2	11316-117D2	70.70	28.15	4.21
Astrocyte - cerebral cortex, donor3	11392-118C6	69.66	27.15	5.82
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	94.27	33.49	6.31
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	101.85	35.71	6.14
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	94.79	32.89	5.23
Basophils, donor1	12241-129G9	124.49	12.82	0.78
Basophils, donor2	12242-129H1	427.54	34.64	3.97
Basophils, donor3	12243-129H2	116.86	15.73	3.38
Bronchial Epithelial Cell, donor1	11511-119G8	22.21	1.51	0.65
Bronchial Epithelial Cell, donor2	11591-120G7	3.66	1.37	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	22.60	5.65	1.88
Bronchial Epithelial Cell, donor5	11457-119A8	16.84	4.16	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	14.28	2.76	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	38.15	10.80	1.98
Burkitt's lymphoma cell line:DAUDI	10422-106C8	78.84	15.87	3.30
Burkitt's lymphoma cell line:RAJI	10476-106I8	126.47	23.52	3.26
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	93.37	35.18	2.56
CD133+ stem cells - cord blood derived, pool1	12223-129E9	382.65	41.37	0.00
CD14+ Monocytes, donor1	11224-116B9	102.57	10.71	1.69
CD14+ Monocytes, donor2	11305-117B9	98.74	10.21	0.93
CD14+ Monocytes, donor3	11381-118B4	98.79	12.07	1.32
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	75.86	18.68	3.40
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	99.70	26.16	7.96
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	103.88	25.97	7.23
CD14+ monocytes - mock treated, donor1	11863-125A9	79.65	28.48	2.75
CD14+ monocytes - mock treated, donor2	11873-125C1	79.66	23.84	1.51
CD14+ monocytes - mock treated, donor3	11883-125D2	95.23	25.35	1.90
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	54.24	15.23	1.51
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	70.93	21.80	2.21
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	82.81	19.59	2.23
CD14+ monocytes - treated with BCG, donor1	11860-125A6	52.08	17.82	1.37
CD14+ monocytes - treated with BCG, donor2	11870-125B7	64.28	20.12	1.96
CD14+ monocytes - treated with BCG, donor3	11880-125C8	103.81	21.76	2.61
CD14+ monocytes - treated with Candida, donor1	11868-125B5	57.13	19.43	1.17
CD14+ monocytes - treated with Candida, donor2	11878-125C6	98.74	22.18	2.64
CD14+ monocytes - treated with Candida, donor3	11888-125D7	79.87	17.75	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	63.07	22.61	1.19
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	75.83	27.54	1.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	96.60	23.53	3.12
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	50.10	17.62	1.14
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	85.96	19.68	2.49
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	65.47	16.15	1.75
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	69.67	21.25	2.96
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	76.59	29.48	1.92
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	94.26	23.99	1.68
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	39.50	13.59	1.47
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	53.19	15.50	1.76
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	60.11	14.92	3.51
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	59.11	21.80	2.27
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	61.70	17.84	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	126.96	26.08	3.23
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	52.00	15.97	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	63.98	17.62	1.62
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	75.63	19.26	2.09
CD14+CD16+ Monocytes, donor1	11789-124B7	66.04	10.68	1.31
CD14+CD16+ Monocytes, donor2	11801-124D1	57.75	9.70	0.69
CD14+CD16+ Monocytes, donor3	11912-125G4	48.52	6.72	0.87
CD14+CD16- Monocytes, donor1	11788-124B6	63.38	10.90	1.71
CD14+CD16- Monocytes, donor2	11799-124C8	51.17	9.78	1.22
CD14+CD16- Monocytes, donor3	11910-125G2	119.07	13.38	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	58.43	10.46	1.28
CD14-CD16+ Monocytes, donor2	11800-124C9	56.43	9.88	1.32
CD14-CD16+ Monocytes, donor3	11911-125G3	74.95	12.21	1.26
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	184.94	34.55	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	189.83	38.64	4.75
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	183.30	36.25	3.11
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	234.54	37.31	4.26
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	207.46	46.10	5.90
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	204.26	40.01	4.91
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	173.34	37.65	4.71
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	159.51	34.28	5.27
CD19+ B Cells, donor1	11544-120B5	310.68	33.70	1.64
CD19+ B Cells, donor2	11624-122B4	332.25	32.64	3.63
CD19+ B Cells, donor3	11705-123B4	338.23	25.24	2.02
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	321.23	30.30	9.29
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	205.74	17.98	6.79
CD34+ Progenitors, donor1	11545-120B6	117.47	14.06	1.00
CD34+ Progenitors, donor2	11625-122B5	257.31	25.28	3.93
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	70.27	21.79	4.51
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	101.24	24.80	3.83
CD4+ T Cells, donor1	11225-116C1	556.29	58.20	3.57
CD4+ T Cells, donor2	11306-117C1	317.82	33.68	1.84
CD4+ T Cells, donor3	11382-118B5	330.61	38.43	2.13
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	165.65	38.29	4.85
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	170.92	37.28	4.04
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	150.92	35.36	4.31
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	302.00	41.25	1.42
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	287.95	41.44	3.51
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	240.62	32.96	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	127.17	26.88	2.75
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	112.18	21.52	2.54
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	91.24	24.50	2.42
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	180.22	23.31	1.79
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	207.89	33.19	3.14
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	292.15	36.52	2.20
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	174.56	32.47	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	97.03	23.69	2.29
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	78.52	17.04	1.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	306.74	47.32	3.26
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	423.40	64.85	5.36
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	225.95	17.93	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	175.42	40.98	2.97
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	127.59	25.56	2.60
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	123.99	26.90	2.94
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	209.32	34.38	2.02
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	200.16	35.96	2.60
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	344.29	55.78	3.92
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	256.84	64.83	8.41
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	245.57	52.62	3.69
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	175.87	48.85	2.79
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	318.19	63.69	8.86
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	396.80	85.40	9.32
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	318.78	61.60	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	237.07	69.83	7.88
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	261.76	66.48	5.54
CD8+ T Cells, donor1	11226-116C2	449.51	40.27	4.58
CD8+ T Cells, donor2	11307-117C2	318.74	29.28	3.75
CD8+ T Cells, donor3	11383-118B6	394.39	37.62	2.78
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	37.39	9.41	0.92
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	28.76	7.91	1.92
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	31.19	12.59	2.74
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	59.14	15.31	1.20
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	43.20	9.36	2.40
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	39.79	12.51	2.50
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	31.94	10.86	1.96
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	36.32	11.05	1.84
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	33.77	13.37	2.35
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	35.32	15.09	1.21
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	31.96	18.88	2.32
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	45.29	16.25	3.46
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	51.65	23.20	3.94
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	53.74	23.68	5.47
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	57.43	30.58	4.48
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	43.94	9.72	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	49.20	11.51	2.30
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	43.13	12.26	3.06
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	42.15	19.01	6.34
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	42.14	17.22	2.46
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	47.13	13.46	1.60
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	41.69	17.21	5.35
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	39.80	16.95	4.73
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	49.17	12.10	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	61.83	17.67	3.21
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	67.15	24.48	4.90
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	72.13	32.06	6.01
Cardiac Myocyte, donor1	11525-119I4	25.59	7.31	1.83
Cardiac Myocyte, donor2	11605-120I3	23.22	13.83	1.98
Cardiac Myocyte, donor3	11686-122I3	29.57	16.42	4.84
Chondrocyte - de diff, donor1	11261-116G1	52.35	12.48	5.55
Chondrocyte - de diff, donor2	11338-117F6	36.25	10.31	1.07
Chondrocyte - de diff, donor3	11410-118E6	26.06	12.52	2.96
Chondrocyte - re diff, donor2	11339-117F7	118.17	32.23	10.74
Chondrocyte - re diff, donor3	11411-118E7	23.05	8.90	3.24
Ciliary Epithelial Cells, donor1	11242-116D9	81.71	36.95	6.31
Ciliary Epithelial Cells, donor2	11323-117D9	37.20	22.02	3.21
Ciliary Epithelial Cells, donor3	11399-118D4	43.01	22.83	4.42
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	72.44	29.07	6.88
Corneal Epithelial Cells, donor1	11526-119I5	9.44	1.10	0.22
Corneal Epithelial Cells, donor2	11606-120I4	18.20	3.41	0.00
Corneal Epithelial Cells, donor3	11687-122I4	18.66	4.60	0.77
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	55.14	26.42	3.96
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	50.47	25.86	2.52
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	51.76	27.61	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	32.72	19.22	2.48
Dendritic Cells - plasmacytoid, donor1	11228-116C4	253.16	16.06	1.02
Dendritic Cells - plasmacytoid, donor2	11309-117C4	242.87	20.24	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	304.40	19.36	2.42
Endothelial Cells - Aortic, donor0	11207-116A1	39.69	19.01	3.34
Endothelial Cells - Aortic, donor1	11263-116G3	17.60	9.98	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	30.82	6.79	1.13
Endothelial Cells - Aortic, donor3	11412-118E8	32.24	11.01	2.75
Endothelial Cells - Artery, donor1	11264-116G4	22.11	10.18	2.91
Endothelial Cells - Artery, donor2	11341-117F9	31.76	17.65	0.94
Endothelial Cells - Artery, donor3	11413-118E9	34.36	18.93	2.45
Endothelial Cells - Lymphatic, donor1	11236-116D3	40.56	22.83	2.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	59.03	34.38	8.22
Endothelial Cells - Lymphatic, donor3	11393-118C7	91.05	38.34	8.18
Endothelial Cells - Microvascular, donor1	11265-116G5	32.68	16.05	2.38
Endothelial Cells - Microvascular, donor2	11342-117G1	29.16	10.41	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	15.17	10.49	1.84
Endothelial Cells - Thoracic, donor1	11266-116G6	60.42	19.61	4.40
Endothelial Cells - Thoracic, donor2	11343-117G2	24.11	8.91	1.57
Endothelial Cells - Umbilical vein, donor1	11243-116E1	74.30	47.34	5.72
Endothelial Cells - Umbilical vein, donor2	11324-117E1	34.33	21.07	1.74
Endothelial Cells - Umbilical vein, donor3	11400-118D5	39.57	21.74	2.44
Endothelial Cells - Vein, donor1	11267-116G7	18.20	5.69	0.00
Endothelial Cells - Vein, donor2	11344-117G3	17.46	7.68	2.79
Endothelial Cells - Vein, donor3	11416-118F3	24.96	11.62	1.26
Eosinophils, donor1	12244-129H3	426.91	60.99	0.00
Eosinophils, donor2	12245-129H4	793.78	66.01	4.95
Eosinophils, donor3	12246-129H5	435.15	28.53	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	11.48	1.71	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	48.81	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	30.79	10.26	2.87
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	16.42	6.68	1.42
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	18.74	8.02	1.95
Fibroblast - Aortic Adventitial, donor1	11245-116E3	38.57	17.71	3.40
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	125.69	27.84	11.19
Fibroblast - Aortic Adventitial, donor2	11326-117E3	33.86	12.34	3.38
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	80.89	28.72	7.90
Fibroblast - Aortic Adventitial, donor3	11401-118D6	39.20	15.95	2.66
Fibroblast - Cardiac, donor1	11268-116G8	29.94	9.07	2.72
Fibroblast - Cardiac, donor2	11345-117G4	28.80	5.31	0.76
Fibroblast - Cardiac, donor3	11417-118F4	17.66	6.62	2.05
Fibroblast - Cardiac, donor4	11452-119A3	73.05	34.86	11.82
Fibroblast - Cardiac, donor5	11456-119A7	39.21	15.86	2.16
Fibroblast - Cardiac, donor6	11460-119B2	33.20	18.34	2.12
Fibroblast - Choroid Plexus, donor1	11492-119E7	48.10	8.98	1.47
Fibroblast - Choroid Plexus, donor2	11572-120E6	51.34	20.28	2.59
Fibroblast - Choroid Plexus, donor3	11653-122E6	13.18	2.93	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	31.14	4.84	1.15
Fibroblast - Conjunctival, donor3	11692-122I9	54.27	28.83	6.44
Fibroblast - Dermal, donor1	11269-116G9	32.63	13.62	2.82
Fibroblast - Dermal, donor2	11346-117G5	35.85	7.55	0.94
Fibroblast - Dermal, donor3	11418-118F5	27.44	8.58	2.30
Fibroblast - Dermal, donor4	11450-119A1	51.77	13.11	3.28
Fibroblast - Dermal, donor5	11454-119A5	55.30	14.65	2.09
Fibroblast - Dermal, donor6	11458-119A9	59.93	19.17	2.92
Fibroblast - Gingival, donor1	11237-116D4	79.75	24.15	5.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	52.92	22.27	4.19
Fibroblast - Gingival, donor2	11318-117D4	56.27	17.66	2.77
Fibroblast - Gingival, donor3	11394-118C8	61.11	15.95	3.67
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	51.94	20.78	4.16
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	23.96	11.28	1.76
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	70.31	31.02	2.96
Fibroblast - Gingival, donor6 (control)	11922-125H5	56.39	23.66	6.36
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	16.59	2.82	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	60.11	24.72	4.83
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	67.36	25.09	6.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	67.13	26.77	3.40
Fibroblast - Gingival, donor9 (control)	11927-125I1	62.07	30.96	5.72
Fibroblast - Lung, donor1	11270-116H1	9.52	8.16	0.00
Fibroblast - Lung, donor2	11347-117G6	56.70	11.94	5.97
Fibroblast - Lung, donor3	11419-118F6	28.70	10.55	3.17
Fibroblast - Lymphatic, donor1	11506-119G3	10.00	1.67	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	11.19	2.80	2.80
Fibroblast - Lymphatic, donor3	11667-122G2	2.24	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	45.47	8.12	1.22
Fibroblast - Mammary, donor2	11620-122A9	0.00	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	35.74	0.00	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	70.99	18.23	3.49
Fibroblast - Periodontal Ligament, donor2	11319-117D5	83.43	29.43	3.64
Fibroblast - Periodontal Ligament, donor3	11395-118C9	129.74	24.78	8.57
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	35.49	14.12	4.20
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	32.13	14.58	2.70
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	28.65	11.60	3.13
Fibroblast - Pulmonary Artery, donor1	11250-116E8	30.73	16.14	2.54
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	26.82	3.45	1.63
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	20.71	6.68	2.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	27.28	12.26	1.98
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	114.70	41.67	7.94
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	55.24	10.30	4.97
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	61.29	14.78	3.55
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	68.90	28.58	6.92
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	87.01	23.53	8.85
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	90.35	25.05	10.12
Fibroblast - skin normal, donor1	11553-120C5	53.82	11.65	3.45
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	89.63	42.51	14.64
Fibroblast - skin normal, donor2	11561-120D4	55.15	21.80	6.93
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	122.41	50.78	10.58
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	68.76	19.80	3.89
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	72.82	31.63	8.03
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	74.55	31.86	7.23
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	65.72	24.29	7.67
Fibroblast - skin walker warburg, donor1	11554-120C6	47.74	12.65	4.05
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	39.36	18.19	3.14
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	265.92	199.44	44.32
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	98.48	14.82	3.49
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	60.50	15.26	3.81
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	74.95	17.70	2.86
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	82.53	15.59	3.58
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	86.51	28.33	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	88.05	31.90	2.55
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	175.15	39.08	3.42
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	170.97	48.26	8.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	77.86	54.11	5.94
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	123.63	32.30	3.37
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	141.42	46.52	5.55
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	71.10	41.09	6.85
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	148.14	34.49	2.21
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	110.80	27.28	4.38
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	83.12	33.13	6.16
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	73.87	25.79	3.22
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	63.19	17.35	2.11
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	70.04	20.90	3.18
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	55.70	16.06	1.02
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	49.97	18.03	2.51
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	61.41	19.93	3.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	61.64	18.14	3.28
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	46.69	27.18	2.07
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	67.72	29.73	3.97
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	63.90	17.87	3.13
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	57.67	19.56	3.83
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	72.78	32.74	4.41
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	91.33	24.74	3.90
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	109.36	29.24	3.64
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	114.76	27.49	3.76
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	73.58	26.11	3.54
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	86.44	22.13	4.49
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	84.53	19.81	2.86
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	63.54	24.76	3.51
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	74.02	23.98	3.80
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	52.20	21.18	3.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	54.67	17.41	3.09
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	68.75	30.87	4.80
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	64.35	23.02	3.24
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	69.27	21.17	4.17
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	58.18	21.22	3.88
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	47.45	17.40	3.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	58.08	26.15	2.13
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	59.38	22.79	3.66
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	52.03	19.98	2.42
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	57.23	20.76	2.24
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	58.70	21.48	3.98
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	43.32	14.17	2.41
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	46.97	20.81	3.21
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	45.99	19.69	2.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	42.83	16.54	1.90
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	54.38	24.70	3.87
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	53.29	23.69	3.73
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	86.28	35.70	6.94
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	50.79	21.50	2.77
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	46.81	14.73	3.23
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	109.54	33.80	5.59
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	211.60	47.38	5.57
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	121.26	40.68	3.54
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	187.81	41.33	4.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	88.25	23.16	1.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	76.29	24.02	2.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	108.38	23.52	4.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	91.57	32.17	7.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	104.44	24.37	2.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	60.97	14.44	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	64.34	19.13	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	78.77	20.51	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	89.36	26.36	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	76.64	16.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	78.58	22.37	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	81.38	22.55	2.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	71.30	21.81	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	87.15	22.58	1.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	93.75	20.72	2.04
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	52.20	14.62	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	79.61	17.75	3.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	52.09	11.54	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	99.95	22.02	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	74.14	36.45	2.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	93.89	34.75	3.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	31.61	10.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	58.43	24.60	4.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	66.50	23.14	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	43.47	10.03	3.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	71.66	21.19	3.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	84.22	38.68	4.11
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	39.76	24.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	79.74	21.23	1.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	63.37	14.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	70.20	19.84	3.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	78.97	26.32	2.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	77.95	22.69	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	88.53	22.43	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	65.35	16.92	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	68.03	17.12	3.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	66.12	21.19	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	54.92	29.25	4.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	52.41	22.32	2.43
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	17.12	10.27	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	22.45	9.98	2.49
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	25.86	4.50	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	38.69	19.35	3.17
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	26.74	15.46	2.09
Hep-2 cells mock treated, biol_rep1	11898-125E8	30.64	9.17	2.20
Hep-2 cells mock treated, biol_rep2	11899-125E9	30.55	11.98	1.52
Hep-2 cells mock treated, biol_rep3	11900-125F1	32.53	7.96	1.82
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	27.22	11.59	2.19
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	33.74	6.02	2.15
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	33.37	7.10	2.15
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	28.15	7.47	1.62
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	33.97	7.38	2.06
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	29.47	8.01	0.96
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	13.99	6.16	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	4.76	1.30	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	23.79	15.86	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	13.76	7.05	2.47
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	3.63	2.91	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	18.01	13.99	2.27
Hepatocyte, donor1	11523-119I2	39.95	4.84	1.21
Hepatocyte, donor2	11603-120I1	53.87	7.54	2.15
Hepatocyte, donor3	11684-122I1	42.95	9.82	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	79.63	20.23	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	108.89	22.72	4.54
Iris Pigment Epithelial Cells, donor1	11530-119I9	40.34	13.31	3.57
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	19.10	0.00	6.37
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	12.46	2.77	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	12.51	2.50	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	23.07	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	19.49	1.62	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	16.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	14.52	3.63	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	18.53	5.29	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	19.96	3.33	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	18.27	3.15	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	15.47	4.64	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	14.86	3.23	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	25.76	3.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	22.82	0.81	2.44
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	17.63	1.68	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	22.50	4.82	1.61
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	17.54	1.85	1.85
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	20.77	4.72	1.42
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	19.05	1.81	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	27.98	7.53	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	17.79	2.54	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	15.30	5.74	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	16.40	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	19.28	3.57	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	6.64	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	16.05	3.70	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	19.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	12.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	14.60	5.56	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	15.49	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	16.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	10.46	3.49	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	18.00	0.00	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	17.42	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	14.93	1.07	3.20
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	6.93	2.77	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	11.40	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	11.97	3.68	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	15.13	0.00	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	21.15	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	71.89	12.81	1.88
Keratinocyte - epidermal, donor2	11349-117G8	15.81	2.93	0.59
Keratinocyte - epidermal, donor3	11421-118F8	43.16	9.37	1.51
Keratinocyte - oral, donor1	11251-116E9	90.59	29.63	3.86
Keratocytes, donor1	11527-119I6	39.20	5.85	2.75
Keratocytes, donor2	11607-120I5	11.72	1.17	1.17
Keratocytes, donor3	11688-122I5	49.99	16.40	3.36
Krukenberg tumor cell line:HSKTC	10687-109F3	54.95	10.99	2.20
Lens Epithelial Cells, donor1	11529-119I8	28.05	21.57	3.24
Lens Epithelial Cells, donor2	11609-120I7	83.38	25.37	7.96
Lens Epithelial Cells, donor3	11690-122I7	94.25	30.27	9.79
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	30.59	18.62	2.37
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	10.88	9.21	1.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	25.82	20.46	0.94
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	16.67	10.75	1.61
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	12.61	7.56	1.58
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	11.86	9.06	1.29
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	20.52	11.49	2.46
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	6.57	4.05	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	14.08	11.82	1.41
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	19.78	10.28	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	18.81	10.66	1.36
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	7.22	5.55	1.11
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	14.98	11.85	2.09
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	11.93	7.63	0.95
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	12.64	6.87	1.10
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	25.87	15.71	1.23
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	5.92	2.81	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	12.44	7.87	2.01
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	18.43	12.84	0.99
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	6.44	8.79	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	8.96	6.72	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	29.58	11.64	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	16.70	11.04	1.35
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	13.78	9.23	1.36
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	12.96	8.81	1.56
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	16.33	10.05	1.26
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	10.68	9.62	2.26
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	27.52	11.69	2.06
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	12.79	9.22	1.13
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	8.38	6.36	1.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	19.38	12.11	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	10.25	4.30	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	10.90	6.44	0.87
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	34.43	18.14	1.48
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	16.06	8.15	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	7.42	5.91	0.69
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	27.34	11.90	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	28.00	14.91	1.22
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	19.18	17.92	2.10
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	22.04	16.00	1.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	9.70	5.33	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	7.31	5.60	0.93
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	17.55	10.74	2.15
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	13.07	9.47	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	6.83	5.41	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	37.99	18.44	3.71
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	9.73	4.10	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	14.92	8.35	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	58.92	31.72	4.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	56.77	22.25	6.90
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	51.21	17.81	3.71
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	52.47	17.35	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	39.39	16.18	3.52
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	48.57	13.08	2.80
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	39.16	17.52	4.12
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	46.39	16.65	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	44.56	17.19	1.81
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	70.38	30.83	4.36
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	78.33	27.01	1.80
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	78.18	24.66	5.42
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	43.14	17.97	2.05
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	75.51	26.46	6.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	66.63	27.98	5.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	47.37	22.41	3.06
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	78.44	38.15	6.40
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	84.08	36.28	5.10
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	50.93	15.95	3.07
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	78.28	26.91	3.26
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	89.75	37.48	4.37
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	84.64	28.31	3.64
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	51.52	16.49	5.15
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	75.77	33.97	5.81
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	86.99	31.69	4.48
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	84.65	33.20	6.64
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	61.51	28.28	4.24
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	72.65	24.71	1.84
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	55.26	17.27	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	56.03	28.78	7.29
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	52.65	19.25	2.26
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	46.77	27.08	2.46
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	63.72	25.31	6.33
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	59.61	21.54	4.31
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	57.51	34.36	4.48
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	57.23	21.55	5.95
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	53.84	18.95	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	61.65	28.26	3.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	67.97	23.99	5.66
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	51.28	18.10	3.62
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	40.53	12.09	3.55
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	49.15	21.31	2.41
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	59.58	12.35	4.29
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	40.40	18.85	5.39
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	58.52	28.52	5.19
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	77.92	18.61	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	17.98	11.64	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	47.62	30.01	6.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	39.98	17.44	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	51.36	26.06	3.83
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	53.77	23.18	4.44
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	46.11	8.47	3.76
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	51.79	18.10	5.03
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	55.88	28.39	4.96
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	55.08	13.77	5.16
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	64.13	18.70	4.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	61.39	24.24	3.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	52.12	17.15	4.62
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	70.05	25.95	3.63
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	77.01	23.19	3.94
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	70.45	22.92	5.03
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	67.13	23.85	5.74
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	65.57	32.01	6.56
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	71.90	24.31	1.52
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	58.64	20.67	2.40
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	69.17	26.64	6.36
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	65.02	17.62	1.82
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	44.27	23.52	5.53
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	66.12	27.74	3.04
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	77.98	17.04	2.58
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	41.72	16.93	3.63
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	64.65	31.06	4.44
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	46.38	11.19	2.13
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	40.80	17.24	1.72
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	56.57	21.60	4.11
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	59.42	16.27	2.83
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	49.37	19.29	4.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	54.50	21.63	2.08
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	54.81	13.31	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	47.60	19.62	5.01
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	41.35	21.84	4.65
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	49.51	14.72	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	50.79	17.11	4.81
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	43.64	23.44	2.83
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	33.96	11.01	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	48.01	12.45	5.33
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	50.72	19.95	5.70
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	44.48	11.50	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	56.36	25.17	3.83
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	48.11	24.50	2.67
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	74.35	19.50	3.12
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	43.77	15.91	1.99
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	45.73	18.71	2.08
Macrophage - monocyte derived, donor1	11232-116C8	50.83	12.31	4.10
Macrophage - monocyte derived, donor2	11313-117C8	44.96	9.54	3.30
Macrophage - monocyte derived, donor3	11389-118C3	38.93	12.45	1.57
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	40.89	9.56	3.19
Mallassez-derived cells, donor2	11929-125I3	97.61	14.10	3.80
Mallassez-derived cells, donor3	11930-125I4	79.22	15.71	2.64
Mammary Epithelial Cell, donor1	11273-116H4	49.02	8.77	3.19
Mammary Epithelial Cell, donor2	11350-117G9	51.25	9.27	2.03
Mammary Epithelial Cell, donor3	11422-118F9	18.71	4.74	1.25
Mast cell - stimulated, donor1	11487-119E2	289.48	368.80	29.83
Mast cell, donor1	11563-120D6	75.70	40.23	9.08
Mast cell, donor2	11565-120D8	146.51	38.63	8.02
Mast cell, donor3	11566-120D9	186.63	27.92	9.46
Mast cell, donor4	11567-120E1	154.42	44.85	8.33
Mast cell, expanded and stimulated, donor5	11940-126A5	96.59	39.03	6.21
Mast cell, expanded and stimulated, donor8	11942-126A7	40.27	29.77	4.67
Mast cell, expanded, donor5	11939-126A4	62.52	20.76	3.21
Mast cell, expanded, donor8	11941-126A6	56.90	24.10	3.01
Melanocyte - dark, donor1	11502-119F8	27.06	13.93	2.19
Melanocyte - dark, donor2	11582-120F7	26.30	16.61	1.38
Melanocyte - dark, donor3	11663-122F7	66.21	10.87	3.11
Melanocyte - light, donor1	11274-116H5	32.68	5.64	1.18
Melanocyte - light, donor2	11351-117H1	19.11	1.36	0.68
Melanocyte - light, donor3	11423-118G1	10.41	8.67	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	38.11	13.12	1.56
Melanocyte, donor2 (MC+2)	12739-135I3	31.47	12.64	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	53.57	10.71	1.87
Meningeal Cells, donor1	11493-119E8	55.33	9.68	1.98
Meningeal Cells, donor2	11573-120E7	40.93	8.80	1.32
Meningeal Cells, donor3	11654-122E7	74.08	20.05	2.85
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	53.04	21.96	3.99
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	46.39	13.79	3.32
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	5.26	2.63	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	3.92	2.62	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	27.27	6.46	2.87
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	42.35	11.65	4.66
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	26.14	8.04	1.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	25.71	8.13	1.98
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	16.80	4.38	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	11.87	5.12	0.82
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	50.97	16.21	5.68
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	12.64	1.12	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	39.74	16.05	3.42
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	14.54	5.04	1.48
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	14.09	6.40	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	34.03	13.47	1.77
Mesenchymal stem cells - hepatic, donor0	11218-116B3	30.02	15.95	4.38
Mesenchymal stem cells - umbilical, donor0	11214-116A8	24.67	12.34	0.73
Mesothelial Cells, donor1	11247-116E5	54.36	17.77	5.57
Mesothelial Cells, donor2	12156-128G5	34.53	12.51	2.00
Mesothelial Cells, donor3	11402-118D7	29.56	12.86	3.18
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	25.66	2.70	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	46.05	16.99	2.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	34.45	10.31	4.12
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	30.06	10.23	1.24
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	32.15	9.96	2.07
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	41.29	13.51	1.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	41.43	9.78	3.26
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	30.48	9.75	1.83
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	32.86	9.50	1.19
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	18.58	7.96	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	25.08	8.36	1.14
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	2.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	24.83	4.67	1.06
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	12.89	2.76	1.84
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	18.18	6.26	1.19
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	0.00	0.00	3.35
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	21.08	6.52	1.76
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	25.43	8.56	0.71
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	6.08	1.11	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	25.10	7.14	0.92
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	26.08	9.68	1.05
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	22.62	8.56	2.45
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	24.89	6.44	1.29
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	20.90	8.89	1.33
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	28.47	8.54	2.41
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	11.15	2.53	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	8.28	0.00	3.31
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	22.83	6.52	1.63
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	22.94	5.29	2.35
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	3.27	1.09	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	24.51	2.40	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	22.81	5.60	2.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	10.97	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	20.02	7.51	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	0.00	2.04
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	21.90	4.38	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	7.73	1.10	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	7.68	1.92	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	30.25	5.21	0.99
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	10.44	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	6.63	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	18.12	5.47	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	6.56	3.06	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	6.39	1.42	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	17.67	5.61	0.84
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	8.31	2.91	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	6.41	1.75	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	16.59	6.94	1.21
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	23.79	10.43	1.67
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	12.93	3.69	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	16.50	4.55	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	13.13	4.15	1.52
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	20.47	6.74	2.07
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	19.30	8.58	1.29
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	3.18	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	14.95	4.80	0.80
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	32.63	14.37	1.80
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	13.84	7.06	1.27
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	16.24	6.05	0.96
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	28.08	13.05	2.21
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	11.76	2.65	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	24.15	7.95	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	29.50	10.57	2.21
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	7.82	1.30	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	24.99	9.11	0.88
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	30.85	14.70	2.02
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	45.34	9.48	2.06
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	28.29	7.15	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	15.07	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	26.73	3.56	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	32.86	5.59	1.97
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	19.99	11.57	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	37.56	15.42	2.17
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	41.91	13.04	7.45
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	33.05	14.27	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	25.57	9.32	2.66
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	42.30	8.26	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	21.37	8.10	2.95
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	35.18	9.53	1.83
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	32.67	7.78	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	10.15	0.53	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	0.00	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	15.15	10.10	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	15.60	7.59	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	20.43	4.09	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	6.36	1.27	1.27
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	10.53	1.62	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	12.08	4.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	85.65	17.13	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	97.87	16.31	6.52
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	23.76	19.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	25.10	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	36.84	10.13	4.09
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	38.67	17.25	2.61
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	16.69	7.34	2.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	16.69	8.76	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	137.09	52.10	11.41
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	33.51	6.38	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	6.80	3.40	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	156.20	51.45	16.54
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	15.90	6.28	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	36.96	10.23	3.72
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	18.92	7.84	0.81
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	36.79	18.92	2.94
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	133.62	89.08	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	20.85	9.43	1.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	51.16	23.55	5.41
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	19.72	8.16	1.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	18.45	6.53	1.63
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	33.17	17.31	4.01
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	22.81	10.08	2.12
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	11.41	3.60	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	151.62	72.53	9.19
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	16.91	6.34	1.46
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	37.39	16.05	2.29
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	14.06	12.66	2.81
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	22.99	11.03	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	24.42	12.21	1.93
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	144.51	66.22	12.07
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	247.79	103.67	22.76
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	24.73	12.48	2.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	25.83	12.70	1.69
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	38.21	17.33	3.56
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	21.89	12.02	3.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	243.75	234.72	18.06
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	31.66	11.66	2.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	23.90	6.76	2.25
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	17.06	9.92	1.59
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	18.57	7.43	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	43.89	18.16	3.41
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	16.62	4.89	1.63
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	14.82	4.36	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	31.66	10.40	2.71
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	13.23	7.06	2.65
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	23.93	12.63	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	20.83	10.42	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	14.93	6.51	2.30
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	51.72	16.63	5.14
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	40.67	14.81	1.77
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	13.55	8.13	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	229.93	117.52	10.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	21.95	5.49	1.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	25.81	3.46	4.41
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	22.70	4.54	0.91
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	18.20	7.91	3.16
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	154.18	66.88	7.94
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	192.20	126.45	5.06
Myoblast, donor1	11241-116D8	41.62	16.52	2.98
Myoblast, donor2	11322-117D8	35.67	18.60	6.52
Myoblast, donor3	11398-118D3	51.29	17.32	7.57
NK T cell leukemia cell line:KHYG-1	10777-110G3	83.04	8.03	1.17
Natural Killer Cells, donor1	11230-116C6	411.77	47.05	2.46
Natural Killer Cells, donor2	11311-117C6	315.73	32.87	2.41
Natural Killer Cells, donor3	11387-118C1	299.46	35.89	2.58
Neural stem cells, donor1	11275-116H6	197.80	74.04	15.97
Neural stem cells, donor2	11352-117H2	433.27	65.47	13.48
Neurons, donor1	11494-119E9	124.03	50.07	5.69
Neurons, donor2	11574-120E8	142.45	25.98	4.40
Neurons, donor3	11655-122E8	99.48	39.46	5.76
Neutrophils, donor1	11233-116C9	542.88	77.95	4.64
Neutrophils, donor2	11314-117C9	298.58	43.48	5.80
Neutrophils, donor3	11390-118C4	756.83	97.73	8.55
Nucleus Pulposus Cell, donor1	11252-116F1	90.12	35.38	6.06
Nucleus Pulposus Cell, donor2	11409-118E5	23.77	10.09	1.63
Nucleus Pulposus Cell, donor3	11462-119B4	35.70	10.03	3.21
Olfactory epithelial cells, donor1	11933-125I7	26.15	9.91	3.72
Olfactory epithelial cells, donor2	11934-125I8	36.19	16.65	2.46
Olfactory epithelial cells, donor3	11935-125I9	28.72	11.80	1.70
Olfactory epithelial cells, donor4	11936-126A1	43.54	13.64	2.14
Oligodendrocyte - precursors, donor1	11496-119F2	45.74	17.45	4.21
Osteoblast - differentiated, donor1	11276-116H7	44.67	11.91	4.04
Osteoblast - differentiated, donor2	11353-117H3	20.58	6.86	0.00
Osteoblast - differentiated, donor3	11425-118G3	11.17	8.07	1.86
Osteoblast, donor1	11277-116H8	21.30	9.58	4.10
Osteoblast, donor2	11354-117H4	70.93	17.56	4.21
Osteoblast, donor3	11426-118G4	35.19	13.51	3.38
Pancreatic stromal cells, donor1	11249-116E7	63.77	25.02	6.49
Pericytes, donor1	11491-119E6	8.01	3.00	0.78
Pericytes, donor2	11571-120E5	9.05	2.94	1.36
Pericytes, donor3	11652-122E5	8.34	4.68	0.20
Perineurial Cells, donor1	11499-119F5	52.89	14.58	3.50
Perineurial Cells, donor2	11579-120F4	37.36	26.78	5.52
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	373.56	37.61	3.82
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	171.89	19.83	1.71
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	222.98	24.07	2.20
Placental Epithelial Cells, donor1	11278-116H9	27.98	4.07	0.72
Placental Epithelial Cells, donor2	11355-117H5	22.18	3.33	1.11
Placental Epithelial Cells, donor3	11427-118G5	15.71	8.64	2.75
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	18.35	6.65	0.32
Preadipocyte - breast, donor1	11467-119B9	31.33	9.94	2.63
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	71.53	23.49	9.01
Preadipocyte - breast, donor2	11328-117E5	27.02	12.16	3.60
Preadipocyte - omental, donor1	11468-119C1	40.60	16.94	3.62
Preadipocyte - omental, donor2	11329-117E6	48.45	12.22	6.98
Preadipocyte - omental, donor3	11403-118D8	28.51	12.18	4.01
Preadipocyte - perirenal, donor1	11469-119C2	11.81	5.91	1.97
Preadipocyte - subcutaneous, donor1	11279-116I1	18.43	3.38	2.15
Preadipocyte - subcutaneous, donor2	11356-117H6	57.73	19.83	5.67
Preadipocyte - subcutaneous, donor3	11428-118G6	33.38	9.88	3.75
Preadipocyte - visceral, donor1	11280-116I2	77.87	20.77	4.75
Preadipocyte - visceral, donor2	11357-117H7	43.26	16.11	5.06
Preadipocyte - visceral, donor3	11429-118G7	34.59	11.39	2.51
Prostate Epithelial Cells (polarized), donor1	11253-116F2	72.11	21.72	3.62
Prostate Epithelial Cells, donor2	11331-117E8	43.20	11.10	1.90
Prostate Epithelial Cells, donor3	11404-118D9	51.38	10.90	1.47
Prostate Stromal Cells, donor1	11254-116F3	34.74	14.12	2.51
Prostate Stromal Cells, donor2	11332-117E9	41.78	13.99	3.59
Prostate Stromal Cells, donor3	11405-118E1	29.09	14.29	5.42
Renal Cortical Epithelial Cells, donor1	11516-119H4	9.12	2.92	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	48.93	13.86	1.73
Renal Epithelial Cells, donor1	11517-119H5	2.54	1.01	0.51
Renal Epithelial Cells, donor2	11597-120H4	4.98	0.71	1.42
Renal Epithelial Cells, donor3	11678-122H4	52.72	18.63	1.91
Renal Glomerular Endothelial Cells, donor1	11514-119H2	6.81	2.04	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	12.80	5.12	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	48.40	26.20	1.78
Renal Glomerular Endothelial Cells, donor4	11783-124B1	5.32	2.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	18.71	4.18	1.54
Renal Mesangial Cells, donor2	11598-120H5	10.03	5.02	2.51
Renal Mesangial Cells, donor3	11679-122H5	3.61	3.33	0.55
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	24.16	4.29	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	5.06	2.95	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	14.85	3.47	0.77
Retinal Pigment Epithelial Cells, donor0	11215-116A9	44.08	7.52	2.33
Retinal Pigment Epithelial Cells, donor1	11528-119I7	27.86	8.81	1.71
Retinal Pigment Epithelial Cells, donor2	11608-120I6	12.35	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	41.40	8.53	3.01
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	95.82	26.59	5.21
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	74.15	8.93	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	145.85	35.77	2.20
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	109.05	23.20	2.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	104.54	12.48	3.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	60.08	11.32	2.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	92.13	10.82	2.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	85.34	14.76	4.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	59.44	10.37	1.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	82.51	13.41	1.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	69.14	10.68	2.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	64.44	11.35	1.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	75.98	9.86	2.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	60.83	10.33	2.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	51.30	11.05	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	51.56	13.28	1.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	69.40	7.65	2.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	56.64	8.76	1.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	112.93	12.59	2.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	59.72	7.43	2.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	61.03	10.61	2.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	64.54	10.69	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	61.73	8.65	2.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	59.99	9.25	1.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	70.07	11.28	2.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	53.24	8.20	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	57.02	8.83	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	66.89	12.49	2.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	71.00	11.56	1.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	61.71	10.32	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	62.20	13.56	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	57.85	12.23	4.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	56.85	11.95	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	59.95	12.53	1.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	68.23	13.32	4.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	48.02	9.37	2.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	60.73	11.95	3.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	68.43	16.16	4.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	52.26	11.39	2.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	67.15	16.09	3.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	65.62	9.88	2.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	64.66	14.65	2.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	57.04	11.20	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	76.46	10.92	1.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	65.72	10.00	1.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	82.23	14.31	2.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	56.22	10.17	2.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	89.09	16.77	2.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	83.41	22.06	3.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	60.46	9.67	2.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	155.16	26.78	5.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	73.01	30.42	3.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	61.49	9.64	3.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	73.06	17.19	2.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	79.98	18.87	2.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	90.44	14.52	4.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	70.65	17.72	2.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	88.94	15.63	2.40
Schwann Cells, donor1	11498-119F4	12.60	1.88	0.38
Schwann Cells, donor2	11578-120F3	30.62	3.40	0.00
Schwann Cells, donor3	11659-122F3	29.80	13.58	1.75
Sebocyte, donor1	11220-116B5	71.21	15.89	2.74
Sebocyte, donor2	11301-117B5	43.20	12.41	1.38
Sebocyte, donor3	11378-118B1	25.56	7.83	1.24
Sertoli Cells, donor1	11255-116F4	31.48	14.91	3.31
Sertoli Cells, donor2	11333-117F1	11.30	5.65	0.00
Skeletal Muscle Cells, donor1	11281-116I3	50.06	12.76	3.43
Skeletal Muscle Cells, donor2	11358-117H8	3.61	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	29.26	3.34	1.67
Skeletal Muscle Cells, donor4	11451-119A2	37.07	17.59	2.67
Skeletal Muscle Cells, donor5	11455-119A6	40.43	15.90	3.12
Skeletal Muscle Cells, donor6	11459-119B1	42.48	18.01	3.85
Skeletal Muscle Satellite Cells, donor1	11240-116D7	82.28	35.66	4.91
Skeletal Muscle Satellite Cells, donor2	11321-117D7	48.37	22.83	3.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	49.31	24.90	3.77
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	68.08	18.70	6.32
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	18.82	5.79	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	15.82	8.81	2.06
Skin - palm, donor1	10286-104F7	42.98	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	32.58	11.24	1.15
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	184.84	39.26	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	34.27	11.04	0.65
Small Airway Epithelial Cells, donor1	11256-116F5	62.69	12.65	2.36
Small Airway Epithelial Cells, donor2	11334-117F2	33.76	14.21	1.97
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	136.81	38.06	8.03
Small Airway Epithelial Cells, donor3	11406-118E2	41.00	9.14	1.35
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	20.06	4.32	0.93
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	66.25	16.67	6.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	27.63	6.47	2.94
Smooth Muscle Cells - Aortic, donor1	11283-116I5	18.56	9.94	2.87
Smooth Muscle Cells - Aortic, donor2	11360-117I1	28.75	5.12	1.18
Smooth Muscle Cells - Aortic, donor3	11432-118H1	30.13	6.18	4.64
Smooth Muscle Cells - Bladder, donor1	11519-119H7	35.03	21.02	2.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	46.84	9.18	2.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	30.37	10.86	2.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	37.26	10.11	2.82
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	50.14	11.07	3.58
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	54.64	19.20	7.38
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	25.06	8.26	1.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	6.34	0.65	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	49.01	22.83	2.74
Smooth Muscle Cells - Carotid, donor1	11285-116I7	20.71	8.08	2.02
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	24.48	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	17.17	1.91	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	45.13	14.30	3.24
Smooth Muscle Cells - Colonic, donor2	11320-117D6	37.24	14.85	2.15
Smooth Muscle Cells - Colonic, donor3	11396-118D1	40.72	13.96	3.78
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	24.13	6.81	1.70
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	8.62	3.23	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	23.91	5.68	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	6.49	3.07	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	64.94	22.62	3.14
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	57.57	24.96	4.33
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	30.26	9.10	2.50
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	16.91	4.23	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	82.92	26.76	4.77
Smooth Muscle Cells - Prostate, donor1	11257-116F6	50.60	13.05	4.26
Smooth Muscle Cells - Prostate, donor2	11335-117F3	30.55	14.78	2.75
Smooth Muscle Cells - Prostate, donor3	11465-119B7	25.62	9.39	4.82
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	45.84	16.74	5.13
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	15.00	11.25	1.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	18.09	20.68	6.46
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	18.14	4.65	4.65
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	29.28	9.59	1.51
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	30.40	9.72	1.57
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	6.49	3.24	0.88
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	75.81	27.32	7.16
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	36.44	16.35	2.80
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	34.83	7.34	1.30
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	24.22	5.86	1.27
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	16.36	4.14	0.56
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	70.99	20.26	5.87
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	41.14	10.81	2.68
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	4.29	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	37.92	4.89	2.45
Smooth Muscle Cells - Uterine, donor1	11258-116F7	40.65	14.80	5.08
Smooth Muscle Cells - Uterine, donor3	11466-119B8	40.38	13.17	5.56
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	52.28	16.33	2.92
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	34.64	11.37	1.32
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	76.25	26.78	2.60
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	48.15	15.81	1.08
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	30.66	10.22	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	44.51	18.51	1.58
Smooth muscle cells - airway, control, donor1	11966-126D4	42.16	13.97	1.52
Smooth muscle cells - airway, control, donor2	11967-126D5	39.93	17.17	1.20
Smooth muscle cells - airway, control, donor3	11968-126D6	32.60	11.29	2.51
Smooth muscle cells - airway, control, donor4	11969-126D7	29.79	11.00	2.75
Synoviocyte, donor1	11291-117A4	48.31	15.82	3.03
Synoviocyte, donor2	11368-117I9	23.64	9.05	2.51
Synoviocyte, donor3	11440-118H9	23.68	8.27	2.68
Trabecular Meshwork Cells, donor1	11532-120A2	20.01	2.86	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	3.96	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	9.49	3.94	0.69
Tracheal Epithelial Cells, donor1	11292-117A5	36.92	6.88	1.15
Tracheal Epithelial Cells, donor2	11369-118A1	17.40	5.41	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	13.74	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	93.01	26.08	5.54
Urethra, donor2	10319-105A4	55.75	23.38	1.80
Urothelial Cells, donor1	11520-119H8	24.44	2.39	0.00
Urothelial Cells, donor2	11600-120H7	10.01	2.00	0.40
Urothelial Cells, donor3	11681-122H7	6.19	1.15	0.46
Urothelial cells, donor0	11216-116B1	59.51	11.37	3.12
Whole blood (ribopure), donor090309, donation1	12179-129A1	371.93	53.39	12.46
Whole blood (ribopure), donor090309, donation2	12180-129A2	398.86	60.04	25.73
Whole blood (ribopure), donor090309, donation3	12181-129A3	168.39	49.97	10.95
Whole blood (ribopure), donor090325, donation1	12176-128I7	280.29	61.29	12.74
Whole blood (ribopure), donor090325, donation2	12177-128I8	242.87	52.29	5.81
Whole blood (ribopure), donor090612, donation1	12182-129A4	327.99	42.69	8.33
Whole blood (ribopure), donor090612, donation2	12183-129A5	373.54	56.90	10.10
Whole blood (ribopure), donor090612, donation3	12184-129A6	168.89	62.08	6.39
Wilms' tumor cell line:G-401	10809-111A8	60.69	20.72	4.44
Wilms' tumor cell line:HFWT	10597-108E3	19.36	5.28	2.64
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	189.10	30.72	5.03
achilles tendon, donor2	10292-104G4	43.40	26.86	8.27
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	94.84	19.12	2.55
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	160.20	32.27	2.79
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	177.47	29.20	2.61
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	118.37	37.01	5.71
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	73.64	31.76	2.81
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	106.80	45.47	4.02
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	120.32	32.12	2.18
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	80.64	14.98	1.76
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	98.41	24.50	4.08
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	122.31	14.37	5.82
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	61.09	13.43	2.02
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	58.51	23.40	7.80
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	96.44	45.08	5.11
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	123.75	22.52	2.33
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	75.98	20.75	2.34
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	46.94	12.08	1.39
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	62.92	10.28	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	33.46	7.37	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	85.34	18.78	6.83
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	106.15	19.11	6.98
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	99.89	24.55	4.09
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	37.64	9.36	2.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	69.38	9.01	1.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	46.46	13.01	5.57
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	128.82	40.68	4.90
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	101.62	33.58	2.62
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	69.36	29.99	7.50
adenocarcinoma cell line:IM95m	10796-110I4	54.64	4.24	1.18
adipose tissue, adult, pool1	10010-101C1	118.51	33.51	4.65
adipose, donor1	10184-103D4	360.06	185.89	24.63
adipose, donor2	10185-103D5	38.93	29.60	4.87
adipose, donor3	10186-103D6	64.80	74.61	9.26
adipose, donor4	10187-103D7	103.14	115.28	24.27
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	61.87	26.20	5.52
adrenal gland, adult, pool1	10081-102A9	54.57	3.64	10.91
adult T-cell leukemia cell line:ATN-1	10421-106C7	75.51	21.21	2.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	91.11	13.58	2.86
amniotic membrane cells, donor1	12235-129G3	69.79	21.10	4.87
amniotic membrane cells, donor2	12236-129G4	55.79	31.44	9.13
amniotic membrane cells, donor3	12237-129G5	68.64	28.58	6.19
amygdala - adult, donor10196	10167-103B5	171.94	66.40	8.30
amygdala, adult, donor10252	10151-102I7	129.57	50.29	10.34
amygdala, newborn, donor10223	10360-105E9	97.15	31.95	3.55
anaplastic carcinoma cell line:8305C	10428-106D5	44.18	10.57	1.02
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	63.54	13.24	3.09
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	140.30	23.05	5.68
aorta, adult, pool1	10052-101G7	74.53	25.89	4.90
appendix, adult	10189-103D9	97.81	24.45	2.72
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	55.72	11.35	2.41
artery, adult	10190-103E1	59.78	12.23	0.00
astrocytoma cell line:TM-31	10425-106D2	89.24	25.06	5.07
b cell line:RPMI1788	10427-106D4	96.51	26.77	2.83
basal cell carcinoma cell line:TE 354.T	10702-109G9	61.04	13.59	6.10
bile duct carcinoma cell line:HuCCT1	10432-106D9	73.73	14.19	3.18
bile duct carcinoma cell line:TFK-1	10496-107C1	100.76	13.56	2.68
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	53.69	7.83	1.68
bladder, adult, pool1	10011-101C2	140.47	29.12	5.32
blood, adult, pool1	10053-101G8	126.23	31.00	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	53.95	8.56	0.00
bone marrow, adult	10192-103E3	82.33	17.55	1.35
brain, adult, donor1	10084-102B3	48.18	22.55	4.10
brain, adult, pool1	10012-101C3	156.46	51.22	11.47
brain, fetal, pool1	10085-102B4	74.80	21.37	10.69
breast carcinoma cell line:MCF7	10482-107A5	116.95	30.39	2.64
breast carcinoma cell line:MDA-MB-453	10419-106C5	120.45	10.98	2.75
breast, adult, donor1	10080-102A8	52.40	21.47	4.42
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	56.02	13.08	3.05
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	76.38	8.35	2.78
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	56.63	21.87	2.53
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	70.93	15.01	3.15
carcinoid cell line:NCI-H1770	10703-109H1	74.76	10.34	0.47
carcinoid cell line:NCI-H727	10735-110B6	72.96	19.36	3.61
carcinoid cell line:SK-PN-DW	10719-109I8	41.20	9.19	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	67.61	29.01	6.39
caudate nucleus - adult, donor10196	10177-103C6	172.70	62.17	10.36
caudate nucleus, adult, donor10252	10164-103B2	177.53	55.89	11.71
caudate nucleus, adult, donor10258	10379-105H1	155.12	35.91	2.29
caudate nucleus, newborn, donor10223	10354-105E3	109.14	35.16	6.96
cerebellum - adult, donor10196	10173-103C2	329.20	113.62	23.31
cerebellum, adult, donor10252	10166-103B4	262.40	105.47	28.82
cerebellum, adult, pool1	10083-102B2	98.65	40.01	11.73
cerebellum, newborn, donor10223	10357-105E6	137.00	63.93	11.62
cerebral meninges, adult	10188-103D8	106.40	35.80	5.29
cerebrospinal fluid, donor2	10294-104G6	34.35	12.43	2.92
cervical cancer cell line:D98-AH2	10552-107I3	56.94	9.35	3.02
cervical cancer cell line:ME-180	10553-107I4	109.04	28.67	4.97
cervix, adult, pool1	10013-101C4	133.86	36.43	8.29
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	58.66	9.61	2.79
chondrosarcoma cell line:SW 1353	10700-109G7	33.96	5.23	1.31
choriocarcinoma cell line:BeWo	10423-106C9	99.67	13.05	2.24
choriocarcinoma cell line:SCH	10785-110H2	55.20	11.83	1.48
choriocarcinoma cell line:T3M-3	10618-108G6	42.69	7.35	1.42
chorionic membrane cells, donor1	12238-129G6	56.13	19.94	4.56
chorionic membrane cells, donor2	12239-129G7	68.81	23.37	6.16
chorionic membrane cells, donor3	12240-129G8	82.42	31.87	3.85
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	53.52	13.13	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	72.23	21.90	3.46
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	74.97	24.29	4.01
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	79.35	11.56	2.57
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	81.27	10.64	3.14
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	68.41	13.85	2.44
chronic myelogenous leukemia cell line:K562	10454-106G4	133.09	11.48	4.71
chronic myelogenous leukemia cell line:KU812	10409-106B4	155.07	48.74	4.43
clear cell carcinoma cell line:JHOC-5	10638-108I8	44.34	15.31	2.06
clear cell carcinoma cell line:TEN	10636-108I6	73.39	9.54	2.60
colon carcinoma cell line:CACO-2	10513-107D9	107.08	26.36	6.41
colon carcinoma cell line:COLO-320	10420-106C6	163.82	17.86	3.80
colon, adult, donor1	10082-102B1	67.83	13.09	2.38
colon, adult, pool1	10014-101C5	100.58	18.45	3.29
colon, fetal, donor1	10070-101I7	46.35	12.98	3.71
common myeloid progenitor CMP, donor1	12130-128D6	105.42	41.25	0.00
common myeloid progenitor CMP, donor2	12134-128E1	150.22	25.04	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	196.32	73.09	12.32
cord blood derived cell line:COBL-a 24h infection	10453-106G3	71.09	37.73	6.64
cord blood derived cell line:COBL-a untreated	10449-106F8	81.22	37.65	9.17
corpus callosum, adult, pool1	10042-101F6	180.11	44.11	11.94
cruciate ligament, donor2	10295-104G7	54.30	42.14	4.05
diaphragm, fetal, donor1	10069-101I6	51.36	23.27	1.61
diencephalon, adult	10193-103E4	82.08	28.08	7.92
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	82.20	14.24	1.61
ductal cell carcinoma cell line:KLM-1	10438-106E6	103.60	14.87	3.08
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	71.25	16.61	2.41
ductus deferens, adult	10196-103E7	64.78	20.43	6.48
duodenum, fetal, donor1, tech_rep1	10071-101I8	66.25	27.36	4.32
duodenum, fetal, donor1, tech_rep2	10071-101I8	98.58	26.48	4.41
dura mater, adult, donor1	10041-101F5	146.51	30.56	6.52
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	25.76	23.54	4.89
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	59.47	26.65	3.01
embryonic pancreas cell line:1B2C6	10604-108F1	46.86	7.40	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	46.62	9.08	3.94
embryonic pancreas cell line:1C3IKEI	10606-108F3	55.88	6.79	2.16
embryonic pancreas cell line:2C6	10603-108E9	65.67	13.13	3.94
endometrial carcinoma cell line:OMC-2	10497-107C2	68.38	22.79	4.69
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	83.19	17.76	5.07
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	30.39	9.65	1.93
epidermoid carcinoma cell line:A431	10426-106D3	70.47	11.12	2.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	56.53	14.63	2.09
epididymis, adult	10197-103E8	62.58	24.28	5.23
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	67.06	12.95	4.61
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	22.81	7.86	1.57
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	44.69	9.57	3.93
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	44.29	10.43	3.44
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	42.12	9.07	3.58
esophagus, adult, pool1	10015-101C6	124.12	23.47	3.40
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	111.33	36.57	12.02
eye - muscle inferior rectus, donor1	10272-104E2	74.85	19.32	0.00
eye - muscle lateral, donor2	10298-104H1	37.88	16.83	2.10
eye - muscle medial, donor2	10299-104H2	22.32	8.93	0.00
eye - muscle superior, donor2	10297-104G9	56.18	24.08	1.15
eye - vitreous humor, donor1	10268-104D7	26.23	14.57	2.91
eye, fetal, donor1	10054-101G9	95.59	37.37	7.12
fibrosarcoma cell line:HT-1080	10758-110E2	27.44	6.03	1.54
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	49.15	13.53	2.14
frontal lobe, adult, pool1	10040-101F4	215.80	53.29	13.51
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	127.91	34.23	5.70
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	125.73	15.91	4.11
gall bladder, adult	10198-103E9	49.25	17.14	2.90
gamma delta positive T cells, donor1	11937-126A2	181.46	58.52	5.37
gamma delta positive T cells, donor2	11938-126A3	189.73	42.20	2.61
gastric adenocarcinoma cell line:MKN1	10614-108G2	50.06	21.33	3.80
gastric adenocarcinoma cell line:MKN45	10612-108F9	76.59	9.48	2.32
gastric cancer cell line:AZ521	10549-107H9	69.35	32.63	8.20
gastric cancer cell line:GSS	10560-108A2	81.46	8.24	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	62.37	19.65	2.28
giant cell carcinoma cell line:LU65	10487-107B1	99.37	13.88	2.41
giant cell carcinoma cell line:Lu99B	10433-106E1	57.10	15.68	3.36
glassy cell carcinoma cell line:HOKUG	10688-109F4	21.95	7.23	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	52.25	9.71	4.22
glioblastoma cell line:A172, tech_rep2	10444-106F3	52.80	13.06	4.63
glioblastoma cell line:T98G	10485-107A8	95.58	22.30	7.28
glioma cell line:GI-1	10413-106B8	47.15	12.01	2.05
globus pallidus - adult, donor10196	10175-103C4	158.90	50.29	8.02
globus pallidus, adult, donor10252	10161-103A8	150.85	46.87	11.72
globus pallidus, adult, donor10258	10367-105F7	127.34	30.12	5.48
globus pallidus, newborn, donor10223	10364-105F4	53.29	30.38	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	73.41	2.45	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	54.64	0.00	10.93
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	5.23	0.00
granulosa cell tumor cell line:KGN	10624-108H3	36.80	14.08	1.28
hIPS +CCl2, biol_rep1	14383-156B9	137.28	33.52	1.84
hIPS +CCl2, biol_rep2	14384-156C1	104.26	25.61	1.83
hIPS +CCl2, biol_rep3	14385-156C2	125.60	28.34	0.64
hIPS, biol_rep1	14380-156B6	156.66	14.37	1.44
hIPS, biol_rep2	14381-156B7	87.11	21.95	0.00
hIPS, biol_rep3	14382-156B8	100.42	46.35	4.41
hairy cell leukemia cell line:Mo	10712-109I1	67.24	23.56	3.16
heart - mitral valve, adult	10205-103F7	77.13	26.61	7.18
heart - pulmonic valve, adult	10206-103F8	93.35	28.24	3.14
heart - tricuspid valve, adult	10207-103F9	40.80	28.31	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	52.65	18.77	3.47
heart, adult, diseased, donor1	10051-101G6	60.47	14.05	5.11
heart, adult, pool1	10016-101C7	69.22	15.87	4.14
heart, fetal, pool1	10046-101G1	134.31	37.07	8.32
hepatic mesenchymal tumor cell line:LI90	10778-110G4	42.88	13.58	1.85
hepatoblastoma cell line:HuH-6	10633-108I3	35.68	3.57	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	79.34	20.55	3.09
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	76.22	23.43	4.85
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	82.06	22.43	4.04
hepatoma cell line:Li-7	10484-107A7	87.53	8.34	3.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	33.67	9.35	1.81
hippocampus - adult, donor10196	10169-103B7	132.49	55.83	4.73
hippocampus, adult, donor10252	10153-102I9	145.32	60.21	14.29
hippocampus, adult, donor10258	10374-105G5	114.03	20.91	4.48
hippocampus, newborn, donor10223	10363-105F3	59.92	26.08	2.47
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	203.85	52.49	5.49
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	84.04	24.54	1.37
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	109.68	27.17	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	131.38	32.14	2.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	88.57	35.12	3.36
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	111.61	32.65	2.28
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	89.34	51.09	4.96
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	75.83	49.55	3.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	67.98	44.63	4.59
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	99.22	51.38	8.76
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	98.36	54.16	8.52
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	123.89	48.48	4.04
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	77.15	27.85	2.19
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	81.06	25.55	3.44
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	148.37	43.64	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	103.66	49.64	7.83
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	98.55	48.84	4.80
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	149.93	73.46	6.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	59.34	46.91	6.78
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	58.20	52.29	8.18
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	67.35	45.73	5.01
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	59.77	69.40	8.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	69.67	64.16	10.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	75.93	57.39	6.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	76.85	21.98	2.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	82.16	20.83	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	140.05	33.48	2.04
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	90.48	50.35	5.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	62.08	39.59	1.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	78.98	42.97	3.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	51.20	59.47	5.69
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	43.83	54.46	7.31
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	61.05	51.56	6.16
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	61.10	51.39	8.44
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	70.42	49.22	9.09
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	80.99	52.09	4.37
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	87.43	22.94	2.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	102.50	28.08	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	117.56	29.76	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	94.13	46.15	3.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	771.02	471.72	29.28
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	157.53	66.19	5.63
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	68.96	49.80	6.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	64.05	41.98	6.88
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	63.70	37.72	2.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	68.02	53.70	4.77
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	125.13	77.60	11.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	66.54	43.64	4.85
immature langerhans cells, donor1	11904-125F5	189.60	31.96	1.70
immature langerhans cells, donor2	11905-125F6	54.66	13.47	0.00
insula, adult, pool1	10039-101F3	208.86	51.95	14.01
keratoacanthoma cell line:HKA-1	10791-110H8	39.02	4.23	1.30
kidney, adult, pool1	10017-101C8	68.49	18.42	4.31
kidney, fetal, pool1	10045-101F9	73.42	24.62	6.37
large cell lung carcinoma cell line:IA-LM	10509-107D5	147.84	48.15	11.22
large cell lung carcinoma cell line:NCI-H460	10839-111E2	31.38	8.16	1.80
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	33.21	4.59	1.10
left atrium, adult, donor1	10079-102A7	65.93	26.15	3.27
left ventricle, adult, donor1	10078-102A6	57.14	20.73	2.02
leiomyoblastoma cell line:G-402	10721-110A1	68.40	10.94	3.56
leiomyoma cell line:10964C	10569-108B2	21.55	8.62	2.51
leiomyoma cell line:15242A	10570-108B3	20.65	6.52	2.17
leiomyoma cell line:15425	10571-108B4	36.91	14.81	3.16
leiomyosarcoma cell line:Hs 5.T	10722-110A2	82.54	12.70	12.70
lens epithelial cell line:SRA 01/04	10647-109A8	59.60	14.64	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	63.28	12.75	0.83
liposarcoma cell line:KMLS-1	10782-110G8	38.12	11.87	2.34
liposarcoma cell line:SW 872	10726-110A6	58.24	15.23	3.41
liver, adult, pool1	10018-101C9	59.64	10.70	2.27
liver, fetal, pool1	10086-102B5	22.58	10.35	0.00
locus coeruleus - adult, donor10196	10182-103D2	88.52	32.23	5.54
locus coeruleus, adult, donor10252	10165-103B3	100.03	38.76	10.89
locus coeruleus, adult, donor10258	10375-105G6	58.40	26.24	3.95
locus coeruleus, newborn, donor10223	10362-105F2	103.47	64.35	8.83
lung adenocarcinoma cell line:A549	10499-107C4	32.38	7.61	1.11
lung adenocarcinoma cell line:PC-14	10408-106B3	73.77	9.65	3.45
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	101.89	19.38	2.77
lung, adult, pool1	10019-101D1	87.65	25.40	3.66
lung, fetal, donor1	10068-101I5	244.59	78.77	14.56
lung, right lower lobe, adult, donor1	10075-102A3	53.61	26.58	2.29
lymph node, adult, donor1	10077-102A5	80.47	30.77	1.89
lymphangiectasia cell line:DS-1	10727-110A7	74.08	13.15	3.07
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	301.40	78.78	14.49
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	129.12	22.94	3.40
mature adipocyte, donor1	12231-129F8	73.26	17.76	4.44
mature adipocyte, donor2	12232-129F9	114.76	21.38	9.34
mature adipocyte, donor3	12233-129G1	119.24	18.97	8.06
mature adipocyte, donor4	12234-129G2	118.18	20.00	6.84
maxillary sinus tumor cell line:HSQ-89	10414-106B9	138.91	15.25	5.00
medial frontal gyrus - adult, donor10196	10170-103B8	148.90	54.15	16.92
medial frontal gyrus, adult, donor10252	10150-102I6	146.94	49.65	11.22
medial frontal gyrus, adult, donor10258	10368-105F8	133.11	46.70	8.58
medial frontal gyrus, newborn, donor10223	10352-105E1	171.45	76.34	9.38
medial temporal gyrus - adult, donor10196	10183-103D3	181.58	74.25	7.76
medial temporal gyrus, adult, donor10252	10156-103A3	143.68	49.66	10.40
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	211.89	26.97	11.56
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	287.07	258.37	43.06
medial temporal gyrus, newborn, donor10223	10353-105E2	89.73	33.38	1.08
medulla oblongata - adult, donor10196	10174-103C3	92.15	46.73	9.09
medulla oblongata, adult, donor10252	10155-103A2	108.05	44.58	12.07
medulla oblongata, adult, pool1	10038-101F2	144.24	41.30	11.84
medulla oblongata, newborn, donor10223	10361-105F1	63.53	41.31	6.60
medulloblastoma cell line:D283 Med	10838-111E1	129.97	20.59	2.66
medulloblastoma cell line:ONS-76	10759-110E3	43.16	10.76	1.47
melanoma cell line:COLO 679	10514-107E1	72.16	17.54	6.47
melanoma cell line:G-361	10465-106H6	54.29	13.30	3.80
meningioma cell line:HKBMM	10691-109F7	23.70	5.25	0.90
merkel cell carcinoma cell line:MKL-1	10843-111E6	175.35	23.79	7.05
merkel cell carcinoma cell line:MS-1	10844-111E7	128.83	30.07	4.67
mesenchymal precursor cell - adipose, donor1	11747-123G1	33.60	15.65	3.53
mesenchymal precursor cell - adipose, donor2	11748-123G2	25.63	11.45	3.09
mesenchymal precursor cell - adipose, donor3	11749-123G3	28.99	7.87	2.90
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	29.92	12.78	3.09
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	33.12	12.32	2.50
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	31.23	8.33	2.78
mesenchymal precursor cell - cardiac, donor1	11752-123G6	25.57	10.13	2.06
mesenchymal precursor cell - cardiac, donor2	11753-123G7	27.60	11.50	2.88
mesenchymal precursor cell - cardiac, donor3	11754-123G8	28.12	11.67	2.92
mesenchymal precursor cell - cardiac, donor4	11755-123G9	32.27	13.77	3.51
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	42.25	16.50	3.13
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	28.32	6.26	1.65
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	36.25	13.28	4.01
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	26.53	8.73	1.75
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	29.81	6.33	3.27
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	23.36	7.19	1.44
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	24.21	7.45	2.28
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	22.57	10.26	1.60
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	55.38	23.08	4.62
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	29.29	9.86	3.74
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	26.08	10.50	3.41
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	23.19	8.47	2.21
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	24.61	9.44	2.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	37.05	12.21	3.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	28.77	15.98	1.83
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	28.90	20.72	3.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	30.10	14.40	5.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	27.11	18.18	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	28.71	18.12	3.06
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	22.00	15.57	3.38
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	18.86	16.90	1.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	27.80	18.54	2.32
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	30.86	16.44	3.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	30.12	13.61	3.12
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	15.62	14.18	2.88
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	47.67	34.47	1.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	24.50	13.76	2.69
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	24.15	14.33	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	24.91	13.75	2.58
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	21.88	8.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	10.33	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	26.63	14.62	1.30
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	26.19	17.46	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	23.46	10.66	2.13
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	19.63	9.81	2.45
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	27.60	10.88	1.55
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	12.59	6.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	16.89	10.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	9.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	26.68	8.30	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	28.02	6.09	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	31.04	13.93	1.90
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	33.46	10.35	2.41
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	27.94	21.49	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	19.96	11.98	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	27.55	6.89	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	22.41	12.63	1.63
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	28.60	12.71	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	31.24	13.56	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	36.16	13.71	1.87
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	37.43	9.36	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	31.93	16.56	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	51.36	17.98	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	26.16	17.21	2.75
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	29.19	11.38	3.46
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	25.79	8.97	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	26.71	12.09	2.54
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	28.61	10.88	3.22
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	19.63	8.72	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	19.01	3.80	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	13.35	7.28	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	13.56	4.52	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	10.71	4.94	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	40.68	15.87	3.17
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	24.99	12.66	2.27
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	23.43	11.20	10.19
mesodermal tumor cell line:HIRS-BM	10696-109G3	64.99	14.70	5.42
mesothelioma cell line:ACC-MESO-1	10493-107B7	73.47	8.98	3.07
mesothelioma cell line:ACC-MESO-4	10494-107B8	56.99	19.69	7.65
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	51.28	8.55	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	53.74	11.61	1.34
mesothelioma cell line:Mero-25	10850-111F4	32.68	8.17	1.13
mesothelioma cell line:Mero-41	10851-111F5	45.96	11.73	2.44
mesothelioma cell line:Mero-48a	10852-111F6	53.59	12.62	1.11
mesothelioma cell line:Mero-82	10853-111F7	25.23	12.88	2.10
mesothelioma cell line:Mero-83	10854-111F8	43.92	10.89	1.19
mesothelioma cell line:Mero-84	10855-111F9	26.54	8.85	0.51
mesothelioma cell line:Mero-95	10856-111G1	33.75	10.15	1.86
mesothelioma cell line:NCI-H2052	10847-111F1	38.43	11.76	1.99
mesothelioma cell line:NCI-H226	10846-111E9	24.07	18.46	2.53
mesothelioma cell line:NCI-H2452	10848-111F2	27.50	11.62	2.22
mesothelioma cell line:NCI-H28	10845-111E8	47.33	12.72	3.05
mesothelioma cell line:No36	10857-111G2	33.27	4.57	0.65
mesothelioma cell line:ONE58	10858-111G3	28.72	6.77	1.08
migratory langerhans cells, donor1	11901-125F2	168.32	34.93	4.22
migratory langerhans cells, donor2	11902-125F3	149.23	23.20	3.05
migratory langerhans cells, donor3	11903-125F4	263.12	42.54	3.77
mixed mullerian tumor cell line:HTMMT	10689-109F5	36.24	7.84	1.96
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	15.90	8.27	0.85
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	87.77	8.98	2.07
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	52.90	14.84	2.47
myelodysplastic syndrome cell line:SKM-1	10772-110F7	95.54	12.20	2.40
myeloma cell line:PCM6	10474-106I6	106.74	25.70	5.34
myxofibrosarcoma cell line:MFH-ino	10600-108E6	31.96	6.59	2.54
myxofibrosarcoma cell line:NMFH-1	10684-109E9	63.94	10.98	2.35
nasal epithelial cells, donor1, tech_rep1	12226-129F3	48.69	5.91	1.56
nasal epithelial cells, donor1, tech_rep2	12226-129F3	54.57	8.53	1.10
nasal epithelial cells, donor2	12227-129F4	30.36	40.30	7.73
neuroblastoma cell line:CHP-134	10508-107D4	256.75	23.47	7.36
neuroblastoma cell line:NB-1	10539-107G8	167.44	40.41	14.59
neuroblastoma cell line:NBsusSR	10607-108F4	129.27	13.29	5.06
neuroblastoma cell line:NH-12	10555-107I6	194.92	38.20	6.71
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	108.17	14.23	4.03
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	86.16	13.78	2.38
neuroectodermal tumor cell line:TASK1	10774-110F9	72.86	15.50	1.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	49.59	2.54	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	39.13	9.58	2.13
neutrophil PMN, donor1	12133-128D9	74.37	0.00	0.00
neutrophil PMN, donor2	12137-128E4	66.40	39.84	0.00
neutrophil PMN, donor3	12141-128E8	94.71	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	349.23	69.17	4.90
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	40.03	16.01	5.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	35.59	13.79	3.53
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	35.21	10.51	3.42
nucleus accumbens, adult, pool1	10037-101F1	224.97	47.90	12.37
occipital cortex - adult, donor10196	10172-103C1	193.68	57.69	12.36
occipital cortex, adult, donor10252	10163-103B1	156.72	55.82	12.34
occipital cortex, newborn, donor10223	10355-105E4	78.25	30.57	2.55
occipital lobe, adult, donor1	10076-102A4	110.73	45.66	9.18
occipital lobe, fetal, donor1	10073-102A1	193.10	79.38	12.01
occipital pole, adult, pool1	10036-101E9	100.92	23.18	6.86
olfactory region, adult	10195-103E6	114.63	37.64	8.79
optic nerve, donor1	10277-104E7	86.05	18.01	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	119.38	16.17	3.53
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	111.83	10.30	1.79
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	63.50	24.38	2.88
oral squamous cell carcinoma cell line:SAS	10544-107H4	41.93	16.98	2.31
osteoclastoma cell line:Hs 706.T	10704-109H2	31.45	13.52	2.35
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	113.05	21.49	9.34
osteosarcoma cell line:HS-Os-1	10558-107I9	87.37	12.51	4.24
ovary, adult, pool1	10020-101D2	131.81	42.98	12.67
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	33.73	9.53	1.10
pancreas, adult, donor1	10049-101G4	63.96	15.99	3.76
pancreatic carcinoma cell line:NOR-P1	10698-109G5	60.94	6.43	2.52
papillary adenocarcinoma cell line:8505C	10437-106E5	49.23	9.88	3.07
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	110.94	28.81	2.65
paracentral gyrus, adult, pool1	10035-101E8	166.94	40.09	11.26
parietal cortex, adult, donor10258	10373-105G4	126.25	41.84	2.20
parietal lobe - adult, donor10196	10171-103B9	125.08	50.79	13.17
parietal lobe, adult, donor10252	10157-103A4	145.65	43.90	13.68
parietal lobe, adult, pool1	10034-101E7	169.10	38.60	14.10
parietal lobe, fetal, donor1	10072-101I9	312.29	79.53	14.55
parietal lobe, newborn, donor10223	10356-105E5	86.74	32.15	3.36
parotid gland, adult	10199-103F1	83.87	22.20	4.32
penis, adult	10200-103F2	75.73	20.95	1.61
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	122.53	6.88	2.79
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	40.07	12.82	3.35
pineal gland - adult, donor10196	10179-103C8	99.33	34.19	7.10
pineal gland, adult, donor10252	10160-103A7	227.41	60.41	17.17
pineal gland, adult, donor10258	10377-105G8	107.23	31.35	8.78
pituitary gland - adult, donor10196	10180-103C9	135.58	88.03	16.19
pituitary gland, adult, donor10252	10162-103A9	333.55	133.42	26.58
pituitary gland, adult, donor10258	10378-105G9	133.64	41.71	14.47
placenta, adult, pool1	10021-101D3	103.96	31.07	4.41
plasma cell leukemia cell line:ARH-77	10840-111E3	67.80	16.69	1.72
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	91.52	25.21	5.60
pons, adult, pool1	10033-101E6	140.72	33.65	12.22
postcentral gyrus, adult, pool1	10032-101E5	123.88	39.32	9.07
promyelocytes/myelocytes PMC, donor1	12132-128D8	52.28	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	77.11	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	46.32	12.53	2.62
prostate cancer cell line:PC-3	10439-106E7	134.67	15.79	4.17
prostate, adult, pool1	10022-101D4	106.56	29.75	8.43
putamen, adult, donor10196	10176-103C5	219.30	68.93	14.87
putamen, adult, donor10252	10152-102I8	90.19	31.37	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	214.19	14.21	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	128.05	42.04	4.35
putamen, newborn, donor10223	10365-105F5	148.43	64.47	8.25
rectal cancer cell line:TT1TKB	10469-106I1	96.01	12.51	4.36
rectum, fetal, donor1	10067-101I4	84.85	37.56	9.74
renal cell carcinoma cell line:OS-RC-2	10411-106B6	99.64	24.17	3.39
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	77.04	7.46	3.73
retina, adult, pool1	10030-101E3	138.76	39.26	9.24
retinoblastoma cell line:Y79	10475-106I7	110.42	11.95	2.86
rhabdomyosarcoma cell line:KYM-1	10787-110H4	73.40	27.05	3.57
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	184.47	52.02	7.87
sacrococcigeal teratoma cell line:HTST	10695-109G2	46.99	12.13	1.52
salivary acinar cells, donor1	11771-123I7	52.44	19.91	2.75
salivary acinar cells, donor2	11772-123I8	60.03	22.58	4.41
salivary acinar cells, donor3	11773-123I9	73.49	12.58	3.31
salivary gland, adult, pool1	10093-102C3	96.66	22.31	2.29
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	43.59	7.67	2.78
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	51.14	8.82	3.29
seminal vesicle, adult	10201-103F3	71.42	25.92	4.76
serous adenocarcinoma cell line:JHOS-2	10639-108I9	67.29	22.83	7.04
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	29.44	4.53	1.51
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	44.16	9.03	3.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	57.09	21.63	1.34
signet ring carcinoma cell line:Kato III	10436-106E4	233.66	25.97	3.32
signet ring carcinoma cell line:NUGC-4	10483-107A6	118.96	18.19	3.48
skeletal muscle - soleus muscle, donor1	10282-104F3	80.15	20.57	1.42
skeletal muscle, adult, pool1	10023-101D5	111.06	14.87	5.16
skeletal muscle, fetal, donor1	10066-101I3	57.29	13.07	3.02
skin, adult, donor1	10074-102A2	40.71	20.36	0.00
skin, fetal, donor1	10065-101I2	107.31	44.82	13.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	96.05	11.34	3.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	107.17	38.46	7.56
small cell lung carcinoma cell line:DMS 144	10841-111E4	73.44	28.91	5.98
small cell lung carcinoma cell line:LK-2	10541-107H1	164.99	32.80	9.07
small cell lung carcinoma cell line:NCI-H82	10842-111E5	60.96	5.15	0.97
small cell lung carcinoma cell line:WA-hT	10562-108A4	100.24	47.94	8.93
small intestine, adult, pool1	10024-101D6	104.03	20.31	3.58
small intestine, fetal, donor1	10064-101I1	68.79	27.03	4.42
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	49.24	13.85	5.13
smooth muscle, adult, pool1	10048-101G3	108.03	25.59	4.65
somatostatinoma cell line:QGP-1	10781-110G7	116.59	20.10	5.09
spinal cord - adult, donor10196	10181-103D1	110.11	47.49	6.88
spinal cord, adult, donor10252	10159-103A6	142.73	41.00	9.46
spinal cord, adult, donor10258	10369-105F9	150.12	47.04	8.99
spinal cord, fetal, donor1	10056-101H2	81.72	37.20	11.59
spinal cord, newborn, donor10223	10359-105E8	126.74	74.39	7.81
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	35.99	11.80	4.03
spleen, adult, pool1	10025-101D7	129.08	33.04	5.51
spleen, fetal, pool1	10044-101F8	95.51	24.87	4.45
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	134.05	28.05	2.69
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	56.58	15.19	2.47
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	79.33	26.56	3.49
squamous cell carcinoma cell line:T3M-5	10616-108G4	80.92	12.12	1.95
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	206.43	34.67	5.52
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	58.88	11.01	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	40.19	10.15	0.85
stomach, fetal, donor1	10062-101H8	85.44	14.95	2.14
submaxillary gland, adult	10202-103F4	105.39	29.62	4.56
substantia nigra - adult, donor10196	10178-103C7	271.37	108.55	0.00
substantia nigra, adult, donor10252	10158-103A5	108.63	32.61	7.06
substantia nigra, adult, donor10258	10371-105G2	113.28	25.86	4.66
substantia nigra, newborn, donor10223	10358-105E7	65.71	24.02	5.65
synovial sarcoma cell line:HS-SY-II	10441-106E9	129.76	27.74	10.32
temporal lobe, adult, pool1	10031-101E4	91.89	29.58	6.44
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	203.71	74.08	11.40
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	166.15	37.36	2.64
tenocyte, donor1	11763-123H8	41.19	19.90	4.54
tenocyte, donor2	11765-123I1	26.32	12.21	3.82
tenocyte, donor3	11768-123I4	30.77	13.34	2.97
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	95.69	13.26	3.91
teratocarcinoma cell line:NCR-G1	10798-110I6	52.26	20.66	2.47
teratocarcinoma cell line:PA-1	10807-111A6	67.11	21.54	1.86
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	44.56	13.08	3.68
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	108.16	23.07	2.27
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	73.07	16.58	6.87
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	71.00	10.75	2.61
testis, adult, pool1	10026-101D8	85.25	45.10	13.10
testis, adult, pool2	10096-102C6	50.97	41.95	5.86
thalamus - adult, donor10196	10168-103B6	141.31	54.10	2.21
thalamus, adult, donor10252	10154-103A1	134.72	40.63	9.38
thalamus, adult, donor10258, tech_rep1	10370-105G1	224.78	21.55	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	60.94	21.24	2.96
thalamus, newborn, donor10223	10366-105F6	72.49	33.37	5.75
throat, adult	10209-103G2	79.89	23.72	5.49
throat, fetal, donor1	10061-101H7	70.08	39.00	9.14
thymic carcinoma cell line:Ty-82	10803-111A2	84.86	22.46	2.58
thymus, adult, pool1	10027-101D9	229.55	44.44	6.26
thymus, fetal, pool1	10043-101F7	223.50	40.11	6.96
thyroid carcinoma cell line:KHM-5M	10776-110G2	46.80	9.04	1.46
thyroid carcinoma cell line:TCO-1	10783-110G9	53.64	10.90	2.51
thyroid, adult, pool1	10028-101E1	81.46	38.72	11.76
thyroid, fetal, donor1	10060-101H6	66.97	35.59	7.38
tongue epidermis (fungiform papillae), donor1	10288-104F9	64.67	9.24	6.16
tongue, adult	10203-103F5	77.22	19.54	2.79
tongue, fetal, donor1	10059-101H5	74.09	26.80	3.15
tonsil, adult, pool1	10047-101G2	204.46	29.75	4.11
trachea, adult, pool1	10029-101E2	86.87	19.80	4.99
trachea, fetal, donor1	10058-101H4	64.24	25.01	3.85
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	41.10	16.65	1.77
transitional-cell carcinoma cell line:5637	10418-106C4	81.97	16.31	3.14
transitional-cell carcinoma cell line:JMSU1	10492-107B6	60.48	12.53	2.82
tridermal teratoma cell line:HGRT	10694-109G1	28.54	11.42	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	81.18	17.10	3.89
umbilical cord, fetal, donor1	10057-101H3	45.90	18.78	4.17
uterus, adult, pool1	10100-102D1	126.26	42.49	11.60
uterus, fetal, donor1	10055-101H1	72.69	33.28	9.73
vagina, adult	10204-103F6	78.19	18.09	0.00
vein, adult	10191-103E2	89.87	26.96	3.07
xeroderma pigentosum b cell line:XPL 17	10563-108A5	51.00	19.76	3.20